SCHEMBL20174206

SCHEMBL20174206

c1ccc(-c2cc(-c3cccc4ccccc34)nc(-c3cccc4c3-c3oc5ccccc5c3C43c4ccccc4-c4ccccc43)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.35
ALDH1A1 P00352 8/20 0.35
HPGD P15428 6/20 0.35
HSD17B10 Q99714 6/20 0.35
MAPK1 P28482 5/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
KDM4E B2RXH2 4/20 0.35
TSHR P16473 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TP53 P04637 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
ATM Q13315 1/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.33
ATR Q13535 1/20 0.33
NPSR1 Q6W5P4 2/20 0.31
GAA P10253 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22326525 0.93 ALDH1A1 (0.38) MAPTALDH1A1HPGDHSD17B10MAPK1
SCHEMBL20174212 0.93 KMT2A (0.33) MAPTALDH1A1HPGDHSD17B10MAPK1
SCHEMBL20174210 0.91 ALDH1A1 (0.36) MAPTALDH1A1HPGDHSD17B10MAPK1
SCHEMBL20174213 0.89 KMT2A (0.33) MAPTALDH1A1HPGDHSD17B10MAPK1
SCHEMBL20179339 0.87
SCHEMBL20174275 0.87 KMT2A (0.32) MAPTALDH1A1HPGDHSD17B10MAPK1
SCHEMBL20174263 0.86 KMT2A (0.36) MAPTALDH1A1HPGDMAPK1KDM4E
SCHEMBL20179204 0.86 MAPK1 (0.30) MAPK1KMT2A
SCHEMBL20174239 0.86 KMT2A (0.33) MAPTALDH1A1HPGDHSD17B10MAPK1
SCHEMBL20174247 0.86 ADORA3 (0.34) MAPTALDH1A1HPGDHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPT 811/4885ALDH1A1 33/4885HPGD 2229/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPT 811/4885ALDH1A1 33/4885HPGD 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.